Study design: There are several conservative methods of painful spasticity treatment. However, conservative methods do not always provide long-term and complete antispastic effects in cases of ...

The triazole MDL 27531, 4-methyl-3-methylsulfonyl-5-phenyl-4H-1,2,4-triazole was identified as an antispastic agent selective for protection against strychnine-induced seizures and hyperreflexia.

First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...

First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...

An extract from Cannabis sativa was approved in May 2011 for patients suffering from moderate to severe muscle spasms due to multiple sclerosis. Since the manufacturer chose a different ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure ...

Among the findings of three new studies, patients with functional dyspepsia were 3.25 times more likely to have disordered sleep than healthy controls; and the muscle-relaxant and antispastic drug ...